Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
80.69 USD | -0.20% | +7.49% | -16.31% |
Chart calendar BioMarin Pharmaceutical Inc.
Upcoming events on BioMarin Pharmaceutical Inc.
Past events on BioMarin Pharmaceutical Inc.
2024-05-21 12:00 pm | Annual General Meeting |
2024-05-15 01:00 pm | BofA Securities Health Care Conference |
2024-05-04 04:00 pm | Pediatric Endocrine Society Meeting - Abstract Number : 6512 |
2024-05-03 01:15 pm | Pediatric Endocrine Society Meeting - Abstract Number : 6831 |
2024-05-03 01:15 pm | Pediatric Endocrine Society Meeting - Abstract Number : 6803 |
2024-05-03 01:15 pm | Pediatric Endocrine Society Meeting - Abstract Number : 6822 |
2024-05-03 01:15 pm | Pediatric Endocrine Society Meeting - Abstract Number : 6813 |
2024-04-24 04:30 pm | Q1 2024 Earnings Call |
2024-04-24 04:03 pm | Q1 2024 Earnings Release |
2024-03-15 10:30 am | American College of Medical Genetics Meeting - Poster #: P144 |
2024-03-15 10:30 am | American College of Medical Genetics Meeting - Poster #: P034 |
2024-03-14 01:30 pm | American College of Medical Genetics Meeting - Oral Session: O03 |
2024-03-14 10:30 am | American College of Medical Genetics Meeting - Poster #: P131 |
2024-03-14 10:30 am | American College of Medical Genetics Meeting - Poster #: P139 |
2024-03-14 10:30 am | American College of Medical Genetics Meeting - Poster #: P141 |
2024-03-14 10:30 am | American College of Medical Genetics Meeting - Poster #: P049 |
2024-03-12 01:35 pm | Barclays Global Healthcare Conference - Fireside Chat |
2024-03-11 | Jefferies Biotech on the Bay Summit |
2024-03-11 10:40 am | Leerink Partners Global Biopharma Conference - Fireside Chat |
2024-03-05 12:50 pm | TD Cowen Health Care Conference - Fireside Chat |
Annual results
Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 1 704 1 708 -0.22% | 1 860 1 851 0.53% | 1 846 1 843 0.2% | 2 096 2 096 -0.02% | 2 419 2 412 0.31% | 2 739 |
EBITDA Million USD | Released Forecast Spread | 4,84 1,92 151.64% | 68,4 106 -35.65% | 25,7 25,6 0.24% | 252 234 7.3% | 262 309 -14.96% | 512 |
EBIT Million USD | Released Forecast Spread | -100 -100,0 -0.47% | -36,8 -17,7 -107.38% | -82,3 -76,7 -7.4% | 150 158 -5.08% | 158 197 -19.91% | 456 |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -94,8 -95,0 0.15% | -42,3 -26,1 -61.91% | -75,4 -75,1 -0.29% | 150 150 -0.48% | 189 230 -18.18% | 473 |
Net income Million USD | Released Forecast Spread | -23,8 -53,0 55.01% | 859 804 6.87% | -64,1 -67,7 5.3% | 142 131 8.47% | 168 190 -11.69% | 365 |
EPS USD | Released Forecast Spread | -0,13 -0,29 55.03% | 4,53 4,24 6.94% | -0,35 -0,37 5.12% | 0,75 0,68 9.89% | 0,87 0,98 -11.21% | 1,85 |
Announcement Date | 26/02/20 | 25/02/21 | 23/02/22 | 27/02/23 | 22/02/24 | - |
Quarterly results
Fiscal Period | December | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 519 509 1.97% | 534 522 2.27% | 505 516 -2.04% | 538 538 -0.13% | 596 570 4.56% | 595 595 0.01% | 581 608 -4.35% | 646 637 1.46% | 649 652 -0.46% | 664 | 693 | 740 | 731 | 747 |
EBITDA Million USD | Released Forecast Spread | 165 41,5 296.86% | 64,4 55,8 15.49% | 22,4 63,4 -64.72% | 0,05 60,6 -99.91% | 85,8 99,4 -13.71% | 51,3 | 41,1 40,5 1.55% | 116 90,7 27.64% | 101 | 79,2 | 128 | |||
EBIT Million USD | Released Forecast Spread | 137 45,1 204.31% | 39,2 30,7 27.55% | -2,42 10,7 -122.55% | -24,5 -4,85 -405.07% | 59,3 40,0 48.39% | 58,9 56,3 4.56% | 25,7 45,7 -43.88% | 14,2 50,9 -72.04% | 88,5 78,3 12.91% | 77,6 | 108 | 136 | 141 | 147 |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 134 65,5 104.78% | 34,9 25,9 34.35% | -1,90 2,90 -165.68% | -17,6 -11,7 -49.75% | 56,8 28,8 96.93% | 70,8 42,3 67.56% | 41,7 52,7 -20.99% | 19,3 55,9 -65.45% | 106 72,1 46.43% | 94,0 | 119 | 146 | 148 | 155 |
Net income Million USD | Released Forecast Spread | 121 56,5 113.91% | 27,7 16,4 68.52% | -6,65 -0,74 -801.15% | -0,25 -12,2 97.95% | 50,9 29,1 74.76% | 56,0 42,5 31.76% | 40,4 42,4 -4.73% | 20,4 43,2 -52.79% | 88,7 61,9 43.19% | 73,1 | 94,0 | 113 | 111 | 120 |
EPS USD | Released Forecast Spread | 0,63 0,24 157.44% | 0,15 0,09 66.57% | -0,04 0,00 -1008.03% | 0,00 -0,07 - | 0,27 0,15 76.85% | 0,29 0,21 37.87% | 0,21 0,22 -4.23% | 0,11 0,22 -50.46% | 0,46 0,33 40.75% | 0,35 | 0,47 | 0,58 | 0,54 | 0,59 |
Announcement Date | 27/04/22 | 03/08/22 | 26/10/22 | 27/02/23 | 26/04/23 | 31/07/23 | 01/11/23 | 22/02/24 | 24/04/24 | - | - | - | - | - |
2024-07-11 02:00 am | BONESUPPORT HOLDING AB: Q2 2024 Earnings Release |
2024-07-15 | SWEDISH ORPHAN BIOVITRUM AB: Q2 2024 Earnings Release |
2024-07-22 | BIOGEN INC.: Q2 2024 Earnings Release (Projected) |
2024-07-23 02:00 am | BIOGAIA AB: Q2 2024 Earnings Release |
2024-07-23 | SAMSUNG BIOLOGICS CO.,LTD.: Q2 2024 Earnings Release (Projected) |
2024-07-24 | PHARMA MAR, S.A.: Q2 2024 Earnings Release (Projected) |
2024-07-24 | GRIFOLS, S.A.: Q2 2024 Earnings Release (Projected) |
2024-07-25 01:00 am | UCB: Q2 2024 Earnings Release |
2024-07-25 | SK BIOSCIENCE CO.,LTD.: Q2 2024 Earnings Release (Projected) |
2024-07-29 | BIOMARIN PHARMACEUTICAL INC.: Q2 2024 Earnings Release (Projected) |
Past sector events for BioMarin Pharmaceutical Inc.
2024-05-23 05:43 am | CONCORD BIOTECH LIMITED: Q4 2024 Earnings Release |
2024-05-14 11:35 am | GRIFOLS, S.A.: Q1 2024 Earnings Release |
2024-05-13 | NATURECELL CO.,LTD.: Q1 2024 Earnings Release |
2024-05-12 | ALTEOGEN INC.: Q1 2024 Earnings Release (Projected) |
2024-05-09 | PHARMARESEARCH CO., LTD.: Q1 2024 Earnings Release |
2024-05-09 | MEDY-TOX INC.: Q1 2024 Earnings Release |
2024-05-09 04:05 pm | AVIDITY BIOSCIENCES, INC.: Q1 2024 Earnings Release |
2024-05-09 04:05 pm | ADMA BIOLOGICS, INC.: Q1 2024 Earnings Release |
2024-05-09 02:30 am | NXERA PHARMA CO., LTD.: Q1 2024 Earnings Release |
2024-05-08 | HUGEL, INC.: Q1 2024 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- BMRN Stock
- Calendar BioMarin Pharmaceutical Inc.